BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 24907681)

  • 1. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.
    Geng Y; Yuan W; Wu F; Chen J; He M; Jin T
    J Control Release; 2008 Sep; 130(3):259-65. PubMed ID: 18620011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
    Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
    J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH.
    Wang C; Yu C; Liu J; Teng L; Sun F; Li Y
    Int J Pharm; 2015 Nov; 495(2):924-31. PubMed ID: 26456269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion.
    Yuan W; Wu F; Guo M; Jin T
    Eur J Pharm Sci; 2009 Feb; 36(2-3):212-8. PubMed ID: 18832030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
    Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres.
    Yu Z; Huang L; Wen R; Li Y; Zhang Q
    Pharm Dev Technol; 2019 Apr; 24(4):395-401. PubMed ID: 30422727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a sustained-release recombinant human growth hormone formulation.
    Kwak HH; Shim WS; Choi MK; Son MK; Kim YJ; Yang HC; Kim TH; Lee GI; Kim BM; Kang SH; Shim CK
    J Control Release; 2009 Jul; 137(2):160-5. PubMed ID: 19332090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK; Chung HJ; Park TG
    J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres.
    Zhao H; Wu F; Cai Y; Chen Y; Wei L; Liu Z; Yuan W
    Int J Pharm; 2013 Jun; 450(1-2):235-40. PubMed ID: 23624084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method.
    He J; Zhou Z; Fan Y; Zhou X; Du H
    J Microencapsul; 2011; 28(8):763-70. PubMed ID: 22034953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stabilization and encapsulation of human growth hormone into biodegradable microspheres.
    Johnson OL; Jaworowicz W; Cleland JL; Bailey L; Charnis M; Duenas E; Wu C; Shepard D; Magil S; Last T; Jones AJ; Putney SD
    Pharm Res; 1997 Jun; 14(6):730-5. PubMed ID: 9210189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
    Wei G; Lu LF; Lu WY
    Int J Pharm; 2007 Jun; 338(1-2):125-32. PubMed ID: 17336005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
    Cleland JL; Jones AJ
    Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism.
    Kim HK; Park TG
    Biotechnol Bioeng; 1999 Dec; 65(6):659-67. PubMed ID: 10550772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of sustained-release microspheres of granulocyte macrophage colony stimulating factor by freezing-induced phase separation with dextran and encapsulation with blended polymers.
    Zhang XR; Zheng Y; Jin T; Chow AH
    J Microencapsul; 2011; 28(8):743-51. PubMed ID: 21967463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
    J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.